2/15/2013

The FDA shouldn't open the way for biosimilars for drugs approved before March 23, 2010, when Congress authorized the creation of a pathway for their approval, the Washington Legal Foundation said. The foundation weighed in to support a petition from Abbott Laboratories on the subject.

Related Summaries